The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
Senators grilled the top executive of Novo Nordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug Wegovy and diabetes drug Ozempic than it does ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...
Read the latest Collecties Wegovy Ozempic news for entrepreneurs and small businesses from Inc. See related articles, photos, ...
Wegovy (semaglutide) is a brand-name drug prescribed for weight management in adults and some children. Wegovy comes as a solution in single-use injection pens. It’s typically injected once per ...
Weight-loss jabs should not be used as an excuse for people to give up on healthy living, the Health Secretary has said. With ...